Cancer

Onco-Innovations Appoints Jared Rushton to Board of Directors

VANCOUVER, BC / ACCESS Newswire / October 30, 2025 / Onco-Innovations Limited (CBOE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN: A3EKSZ) ("Onco" or the "Company"),is pleased to…

2 months ago

QDCME MARKS ONE-YEAR ANNIVERSARY WITH LAUNCH OF CURATED AI AND MICROLEARNING PLATFORMS ADDRESSING ONCOLOGY AND PRIMARY CARE EDUCATIONAL NEEDS

Amid growing clinician shortages and rising cancer incidence, QDcme introduces adaptive AI-based learning for community oncologists and curated microlearning for nurse practitioners…

2 months ago

Koning Advances Women’s Health: A Month of Milestones in Breast Imaging Innovation

As Breast Cancer Awareness Month concludes, Koning reflects on meaningful progress in access, awareness, and global expansion. NORCROSS, Ga., Oct.…

2 months ago

Surgical Automations Announces Closing of $3.4 Million Oversubscribed Seed Round

DALLAS, Oct. 30, 2025 /PRNewswire/ -- Surgical Automations, a stealth-mode surgical-robotics company leveraging AI and automation to transform gastrointestinal endoscopy,…

2 months ago

Amigo Establishes Medical Advisory Board and Appoints Dr. Jay Shah as Chief Medical Advisor

Stanford Health Care's Chief of Medical Staff to Guide Clinical Strategy for Healthcare AI Platform NEW YORK, Oct. 30, 2025…

2 months ago

Biocare Medical and Hamamatsu Announce Strategic Collaboration to Deliver Integrated Spatial Biology Solutions

SAN FRANCISCO and BRIDGEWATER, N.J., Oct. 30, 2025 /PRNewswire/ -- Biocare Medical, a global leader in immunohistochemistry instrumentation, antibodies and…

2 months ago

Google Cloud to Host Second-Annual Cancer AI Symposium in New York City

Leading organizations, researchers, clinicians, and venture capital firms converge to accelerate AI-driven innovation across the cancer continuum NEW YORK, Oct.…

2 months ago

ChemDiv’s Discovery Platform Enables Differentiated, Reversible Pan‑EGFR Kinase Inhibitors for GFR‑Mutant Lung Cancer

Upgraded design + synthesis engine targets broad mutant coverage with wild‑type EGFR sparing; active collaboration advances toward scale‑up and CMC…

2 months ago

Intensity Therapeutics, Inc. Announces Publication of Clinical Results of INT230-6 for the Treatment of Metastatic or Refractory Cancers in eBioMedicine, a Lancet Discovery Science Journal

The paper features a comprehensive evaluation of data, including disease control rate, overall survival, immune activation, abscopal effects, tumor necrosis,…

2 months ago

Medical Care Technologies Inc. (OTC Pink:MDCE) Ranked #1 on InvestorHub Breakout Boards as Company Expands Across Technology and Collectibles Divisions

MESA, ARIZONA / ACCESS Newswire / October 30, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE), a diversified holding company…

2 months ago